Iron chelation with oral deferiprone in patients with thalassemia. - Suppr | 超能文献

Iron chelation with oral deferiprone in patients with thalassemia.

作者信息

Stella M, Pinzello G, Maggio A

出版信息

N Engl J Med. 1998 Dec 3;339(23):1712; author reply 1713-4.

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Iron chelation with oral deferiprone in patients with thalassemia.

N Engl J Med. 1998 Dec 3;339(23):1712; author reply 1713-4.

2

Iron chelation with oral deferiprone in patients with thalassemia.

N Engl J Med. 1998 Dec 3;339(23):1711-2; author reply 1713-4.

3

Iron chelation with oral deferiprone in patients with thalassemia.

N Engl J Med. 1998 Dec 3;339(23):1710; author reply 1713-4. doi: 10.1056/NEJM199812033392313.

4

Oral iron chelation therapy for thalassaemia: an uncertain scene.地中海贫血的口服铁螯合疗法：前景不明。

Br J Haematol. 2000 Oct;111(1):2-5. doi: 10.1046/j.1365-2141.2000.02406.x.

5

Long-term safety and effectiveness of iron-chelation therapy with deferiprone for thalassemia major.去铁酮用于重型地中海贫血的铁螯合疗法的长期安全性和有效性

N Engl J Med. 1998 Aug 13;339(7):417-23. doi: 10.1056/NEJM199808133390701.

6

Iron chelation with oral deferiprone in patients with thalassemia.

N Engl J Med. 1998 Dec 3;339(23):1710-1; author reply 1713-4.

7

Iron chelation with oral deferiprone in patients with thalassemia.地中海贫血患者口服去铁酮的铁螯合作用

N Engl J Med. 1998 Dec 3;339(23):1713-4. doi: 10.1056/nejm199812033392320.

8

Iron chelation with oral deferiprone in patients with thalassemia.

N Engl J Med. 1998 Dec 3;339(23):1712; author reply 1713-4.

9

Pharmacotherapy of iron overload in thalassaemic patients.地中海贫血患者铁过载的药物治疗

Expert Opin Pharmacother. 2003 Oct;4(10):1763-74. doi: 10.1517/14656566.4.10.1763.

10

Clinical monitoring and management of complications related to chelation therapy in patients with β-thalassemia.β-地中海贫血患者螯合治疗相关并发症的临床监测与管理。

Expert Rev Hematol. 2016;9(2):151-68. doi: 10.1586/17474086.2016.1126176. Epub 2015 Dec 19.

引用本文的文献

1

Serum carnitine levels in patients with homozygous beta thalassemia: a possible new role for carnitine?

Eur J Pediatr. 2005 Mar;164(3):131-4. doi: 10.1007/s00431-004-1590-y. Epub 2004 Nov 30.

2

Friedreich ataxia-update on pathogenesis and possible therapies.弗里德赖希共济失调——发病机制及可能治疗方法的最新进展

Neurogenetics. 2004 Feb;5(1):1-8. doi: 10.1007/s10048-003-0170-z. Epub 2003 Dec 19.

3

Deferiprone: a review of its clinical potential in iron overload in beta-thalassaemia major and other transfusion-dependent diseases.去铁酮：对其在重型β地中海贫血及其他依赖输血疾病的铁过载中临床潜力的综述

Drugs. 1999 Sep;58(3):553-78. doi: 10.2165/00003495-199958030-00021.